P-54 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced MSS-colorectal cancer
Kim, R., Mamdani, H., Barve, M., Johnson, M., Sahin, I., Kopetz, S., Yang, S., Lee, B., Adebanjo, T., Georgevitch, R., Ferrando-Martinez, S., Chaney, M., Fan, J., Naing, A.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
P-48 Phase 2a study of NT-I7, a long-acting interleukin-7, plus pembrolizumab: Cohort of subjects with checkpoint inhibitor-naïve advanced pancreatic cancer
Naing, A., Mamdani, H., Barve, M., Johnson, M., Wolff, R., Kim, D., Yang, S., Lee, B., Adebanjo, T., Georgevitch, R., Ferrando-Martinez, S., Haymaker, C., Chaney, M., Fan, J., Kim, R., Pant, S.
Published in Annals of oncology (01.06.2022)
Published in Annals of oncology (01.06.2022)
Get full text
Journal Article
Therapeutic study of a tetracycline hydrochloride and alpha-amylase combination
Broustet, A, Beylot, J, Lorin, J C, Georgevitch, R, Boudey, F
Published in Bordeaux medical (01.07.1970)
Get more information
Published in Bordeaux medical (01.07.1970)
Journal Article